Literature DB >> 31513033

Overview of breast cancer.

Elyse J Watkins1.   

Abstract

Each year, more than 250,000 women in the United States are diagnosed with invasive breast cancer. Although overall mortality for breast cancer patients has declined, it is still the second most common cause of cancer death in women. This article provides an overview of nonmetastatic breast cancer in women, including general features, diagnostic considerations, and treatments for the most common breast cancer subtypes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31513033     DOI: 10.1097/01.JAA.0000580524.95733.3d

Source DB:  PubMed          Journal:  JAAPA        ISSN: 0893-7400


  15 in total

1.  Racial disparities in routine health checkup and adherence to cancer screening guidelines among women in the United States of America.

Authors:  Amarachukwu F Orji; Takashi Yamashita
Journal:  Cancer Causes Control       Date:  2021-07-03       Impact factor: 2.506

2.  CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression.

Authors:  Amlan Das; Inamul Haque; Priyanka Ray; Arnab Ghosh; Debasmita Dutta; Mohiuddin Quadir; Archana De; Sumedha Gunewardena; Indranil Chatterjee; Snigdha Banerjee; Scott Weir; Sushanta K Banerjee
Journal:  Pharmacol Res Perspect       Date:  2021-04

3.  Anticancer Effect of Metformin in Herceptin-Conjugated Liposome for Breast Cancer.

Authors:  Ji-Yeon Lee; Dae Hwan Shin; Jin-Seok Kim
Journal:  Pharmaceutics       Date:  2019-12-20       Impact factor: 6.321

4.  MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR Pathway.

Authors:  Jingyun Guo; Can Luo; Yuqin Yang; Jianyu Dong; Zhaoze Guo; Jinlamao Yang; Huining Lian; Changsheng Ye; Minfeng Liu
Journal:  Cancer Manag Res       Date:  2021-01-15       Impact factor: 3.989

Review 5.  Antioxidants for the Treatment of Breast Cancer: Are We There Yet?

Authors:  Carmen Griñan-Lison; Jose L Blaya-Cánovas; Araceli López-Tejada; Marta Ávalos-Moreno; Alba Navarro-Ocón; Francisca E Cara; Adrián González-González; Jose A Lorente; Juan A Marchal; Sergio Granados-Principal
Journal:  Antioxidants (Basel)       Date:  2021-01-31

6.  Cell Fusion of Mesenchymal Stem/Stromal Cells and Breast Cancer Cells Leads to the Formation of Hybrid Cells Exhibiting Diverse and Individual (Stem Cell) Characteristics.

Authors:  Jessica Dörnen; Ola Myklebost; Thomas Dittmar
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

Review 7.  Shared Decision-Making in Breast Reconstruction for Breast Cancer Patients: A Scoping Review.

Authors:  Xuejing Li; Meiqi Meng; Junqiang Zhao; Xiaoyan Zhang; Dan Yang; Jiaxin Fang; Junxin Wang; Liu Han; Yufang Hao
Journal:  Patient Prefer Adherence       Date:  2021-12-10       Impact factor: 2.711

8.  Discordance in ER, PR, HER2, and Ki-67 Expression Between Primary and Recurrent/Metastatic Lesions in Patients with Primary Early Stage Breast Cancer and the Clinical Significance: Retrospective Analysis of 75 Cases.

Authors:  Li Peng; Zhen Zhang; Dachun Zhao; Jialin Zhao; Feng Mao; Qiang Sun
Journal:  Pathol Oncol Res       Date:  2021-04-09       Impact factor: 3.201

9.  Using Phosphatidylinositol Phosphorylation as Markers for Hyperglycemic Related Breast Cancer.

Authors:  Nirupama Devanathan; Sandra Jones; Gursimran Kaur; Ann C Kimble-Hill
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

10.  Development of Innovative Formulations for Breast Cancer Chemotherapy.

Authors:  Ana Isabel Fraguas-Sánchez; Ana Isabel Torres-Suárez
Journal:  Cancers (Basel)       Date:  2020-11-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.